Popular — and pricey — blood thinners and diabetes drugs are on the list.
Farxiga, a drug for diabetes, heart failure and chronic kidney diseaseFiasp and NovoLog, for diabetes
Drugmakers will have 30 days to sign an agreement to participate in the negotiations, or they may face tax penalties. The tax could be lifted if a drugmaker chooses to pull its drug from the Medicare program entirely. Doing so, however, would cut the company off from a huge share of the market. "Today’s announcement is the result of a rushed process focused on short-term political gain rather than what is best for patients," Stephen Ubl, the president and CEO of the Pharmaceutical Research and Manufacturers of America, a group that represents the drug industry, said in a statement."Politics should not dictate which treatments and cures are worth developing and who should get access to them.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
US government names first 10 drugs for Medicare price negotiationThe Biden administration on Tuesday released its list of 10 prescription medicines including blood thinner Eliquis from Bristol Myers Squibb and Pfizer that will be subject to the first-ever price negotiations by the Medicare health program.
Lire la suite »
US to name first 10 drugs for Medicare price negotiationThe Biden administration on Tuesday is expected to release its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people.
Lire la suite »
Biden administration unveils first 10 drugs subject to Medicare price negotiationsThe announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans.
Lire la suite »
US to name first 10 drugs for Medicare price negotiation By ReutersUS to name first 10 drugs for Medicare price negotiation
Lire la suite »
Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiationsMedicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...
Lire la suite »